You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
Thomas Schinecker, Kip Miller, Kevin McKernan
Beckman Coulter Genomics Target Capture Sequencing Service; Illumina TruSeq Custom Enrichment; Ion Torrent Barcoding, Library Quantitation, Ion Sphere Control Kits
Beckman Coulter announced changes to its board, Steven Salzberg moves to Johns Hopkins, Complete Genomics names a new senior vice president and chief commercial officer, and more.
The tender offer period finished with around 92 percent of Beckman Coulter shareholders tendering their shares.
Danaher commenced a subsequent offering period set to expire on June 29, after which it expects to complete its purchase of Beckman Coulter.
The European Commission approved the deal, clearing the way for Danaher to complete the $6.8 billion purchase by the end of the month.
President and CEO J. Robert Hurley is now also interim Diagnostic Division President, while Scott Atkins was named president of the Life Science Division.
The company said that it anticipates regulatory approval from the European Commission on or about June 16 and to close the acquisition by the end of the month.
The company's Clinical Diagnostics segment was up 3 percent year over year, while Life Science slid 11 percent.
The trials will evaluate biomarker panels for lung, colon, and prostate cancer, and may include a comparison of proteomics-based lung cancer tests from Somalogic and Celera.
Researchers have developed a robotic lab assistant, the Verge reports.
CBC News reports Canada's Supreme Court is to rule on the constitutionality of the country's genetic non-discrimination law today.
The Associated Press reports the World Health Organization is sending experts to China to investigate the animal source of SARS-CoV-2.
In Science this week: atlas of affected cell populations in idiopathic pulmonary fibrosis, and more.